No Data
No Data
Danaher Insider Sold Shares Worth $3,129,424, According to a Recent SEC Filing
Danaher Corporation (DHR): Among Charles Akre's and John Neff's Stock Picks With Huge Upside Potential
Kytopen And Aldevron Announce Joint Marketing Agreement To Enhance Workflow Solutions For Cell Therapy Manufacturers
Jim Cramer on Danaher Corporation (DHR): From Best to Worst Amid China Struggles
Live Cell Imaging Market Worth US$4.75 Billion in 2030 With 8.68% CAGR | MarketsandMarkets
Notable Healthcare Headlines for the Week: Merck, Roche and Bausch Health in Focus